About
Technology
Issues
FAQ
Links
Official Page
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.